Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Healthcare Biotechnology
Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Quantum BioPharma Ltd
Bullboard Posts
User Avatar Image
(827)
•••
Comment by 1hot-techwomanon Mar 12, 2019 2:31pm
95 Views
Post# 29474575

RE:RE:RE:Outa HUGE and into AUXLY !!!

RE:RE:RE:Outa HUGE and into AUXLY !!!
srtman03 wrote:
mousetrap1 wrote:
srtman03 wrote: Don’t like what I’m seeing unfolding with HUGE to many shares outstanding and running low on cash they will need to complete buildout . Raising more cash at this level would be suicide for investors. Auxly has $236 million and many other  revenue streams that will come online soon and can weather the storm !! Just stating facts !
GLTA !!!



Thanks for the post. You just proved where this drop was suspected to have started. We will be able to buy and sell Auxley when this is over. Get lost!



Hey I have seen it before with Tom Faifull's other company 12 years ago Dynamic Fuels went from all the hype on Hydrogen fuel cells that would be worth 100's of millions..lol Now were doing same thing ( with grow ops) back then it ran up to a dollar then went to nothing eventually...insiders made HUGE ( no pun intended ) lol and retail investors got screwed. Don't believe me? Look it up.....all I can say is good luck !!!


Things that make you go MMMM.......
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities